Is Your Child's Allowance Undermining Your Retirement?
The $1,000 Challenge, Part 9: Nibbling Away at the Family Food Bills
The Benefits of Filing Your Taxes Early
After Market: Stocks Finish Wild Week with a Whimper
Merck & Co., Inc.
View this photo on glassdoor.com
Merck’s Noxafil Approved at New Dose for Intravenous Use
UPDATE: FDA Approves Merck Noxafi Injection for IV Use
FDA Approves Merck’s NOXAFIL® (posaconazole) Injection (18 mg/mL) for Intravenous Use
Hologic (HOLX) Appoints New COO; CFO Muir to Retire, Co. Will Commence Search
Merck-Mxico SA in Consumer Health (Mexico) - new company profile report published
Oncothyreon CEO Discusses Q4 2013 Results - Earnings Call Transcript
Merck Animal Health offers statement on beta-agonist report
Pfizer's Breakthrough Vaccine Could Be A Victim Of Its Own Success
Veeva: Irrefutable Proof Of TAM Overstatements, CRM Seat Saturation, Drastic Growth Deceleration, And Highly Dubious Sell-Side Coverage
Tetraphase Pharmaceuticals Adds Nancy J. Wysenski to Board of Directors